Literature DB >> 17951348

Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity.

Paul D Humphries1, Neil J Sebire, Marilyn J Siegel, Øystein E Olsen.   

Abstract

PURPOSE: To prospectively assess whether there is a relationship between the apparent diffusion coefficient (ADC) and the histopathologic cell count and whether the ADC can enable differentiation of benign and malignant extracranial mass lesions in children.
MATERIALS AND METHODS: Institutional ethics approval and parent or guardian consent were obtained. Eleven malignant and eight benign lesions in 19 children (11 girls, eight boys; median age, 3.9 years; age range, 11 days to 15.5 years) who underwent magnetic resonance (MR) imaging of extracranial mass lesions-including a diffusion-weighted sequence (with b values 0, 500, and 1000 sec/mm(2))-and histopathologic analysis to prove findings were studied. The median ADC within each mass lesion was compared with the median cell count for 10 high-power microscopic fields in the specimen. The inverse regression between cell count and ADC was calculated. The difference in ADC between benign and malignant lesions was assessed by using the Mann-Whitney U test.
RESULTS: There was an inverse relationship between ADC and cell count, expressed as ADC (in x10(-3) mm(2)/sec) = 0.56 + (66.2/cell count), with a relatively good fit to the observed data (analysis of variance R(2) = 0.541, F = 20.0, P < .001). The ADCs of benign lesions ranged from (0.84-2.83) x 10(-3) mm(2)/sec (median, 1.35 x 10(-3) mm(2)/sec; standard deviation, 0.68). The ADCs of malignant lesions ranged from (0.73-1.53) x 10(-3) mm(2)/sec (median, 1.00 x 10(-3) mm(2)/sec; standard deviation, 0.29). There was no significant difference in ADC between benign and malignant lesions (Mann-Whitney U = 22, P = .069). All highly cellular (>150 cells per high-power field) lesions had an ADC lower than 1.5 x 10(-3) mm(2)/sec.
CONCLUSION: Although there is a significant relationship between cellularity and ADC, cell count probably is not the sole determinant of the ADC. Use of the ADC cannot enable accurate differentiation of malignant and benign lesions. (c) RSNA, 2007.

Entities:  

Mesh:

Year:  2007        PMID: 17951348     DOI: 10.1148/radiol.2452061535

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  98 in total

1.  Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Authors:  Keiichiro Nakamura; Ikuo Joja; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

2.  Utility of diffusion-weighted imaging in the presurgical diagnosis of an infected urachal cyst.

Authors:  Manil Chouhan; Peter Cuckow; Paul D Humphries
Journal:  Pediatr Radiol       Date:  2010-08-14

Review 3.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

4.  MR findings of primary bone lymphoma in a 15-year-old girl: emphasis on diffusion-weighted imaging.

Authors:  Kevin M Garrett; Hee Kyung Kim; Jerzy Stanek; Kathleen H Emery
Journal:  Pediatr Radiol       Date:  2010-11-13

5.  Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.

Authors:  Daniel C Colvin; Mary E Loveless; Mark D Does; Zou Yue; Thomas E Yankeelov; John C Gore
Journal:  Magn Reson Imaging       Date:  2010-12-28       Impact factor: 2.546

Review 6.  Diffusion-weighted MRI for assessment of early cancer treatment response.

Authors:  Stefanie Galbán; Jean-Christophe Brisset; Alnawaz Rehemtulla; Thomas L Chenevert; Brian D Ross; Craig J Galbán
Journal:  Curr Pharm Biotechnol       Date:  2010-09-01       Impact factor: 2.837

7.  Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.

Authors:  C Baunin; G Schmidt; K Baumstarck; C Bouvier; J C Gentet; A Aschero; A Ruocco; B Bourlière; G Gorincour; C Desvignes; N Colavolpe; G Bollini; P Auqier; P Petit
Journal:  Skeletal Radiol       Date:  2012-02-09       Impact factor: 2.199

8.  Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.

Authors:  Jared A Weis; Michael I Miga; Thomas E Yankeelov
Journal:  Comput Methods Appl Mech Eng       Date:  2016-09-01       Impact factor: 6.756

9.  Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer.

Authors:  David A Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Vito Quaranta; Thomas E Yankeelov
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-13       Impact factor: 7.038

10.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

Authors:  Anwar R Padhani; Guoying Liu; Dow Mu Koh; Thomas L Chenevert; Harriet C Thoeny; Taro Takahara; Andrew Dzik-Jurasz; Brian D Ross; Marc Van Cauteren; David Collins; Dima A Hammoud; Gordon J S Rustin; Bachir Taouli; Peter L Choyke
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.